Nikolaos Tsavaris
Overview
Explore the profile of Nikolaos Tsavaris including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
334
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Symeonidis D, Lazaris A, Zizi Zerbetzoglou A, Christodoulou P, Kavantzas N, Tsavaris N, et al.
J BUON
. 2020 Oct;
25(4):1827-1831.
PMID: 33099920
Purpose: G-protein receptors belong to a large family of receptors which includes more than 800 kinds. An interest for these receptors arose upon noticing their expression on skin, intestine and...
2.
Karadima M, Saetta A, Chatziandreou I, Lazaris A, Patsouris E, Tsavaris N
Pathol Oncol Res
. 2016 Apr;
22(4):707-14.
PMID: 27033063
Our aim was to evaluate the predictive and prognostic influence of BRAF mutation and other molecular, clinical and laboratory parameters in stage IV colorectal cancer (CRC). 60 patients were included...
3.
Sakellariou S, Fragkou P, Levidou G, Gargalionis A, Piperi C, Dalagiorgou G, et al.
BMC Cancer
. 2016 Mar;
16:174.
PMID: 26931562
Background: Advanced glycation end products (AGEs) and their receptor RAGE emerge as important pathogenic contributors in colorectal carcinogenesis. However, their relationship to the detoxification enzyme Glyoxalase (GLO)-I and Adiponectin receptors...
4.
Amptoulach S, Lazaris A, Giannopoulou I, Kavantzas N, Patsouris E, Tsavaris N
Med Oncol
. 2014 Dec;
32(1):416.
PMID: 25476481
There is strong evidence that tumor growth is not only a result of uncontrolled cell proliferation but also of decreased apoptosis. Caspase-3 is a member of interleukin-1 beta-converting enzyme which...
5.
Gargalionis A, Korkolopoulou P, Farmaki E, Piperi C, Dalagiorgou G, Adamopoulos C, et al.
Int J Cancer
. 2014 Aug;
136(7):1515-27.
PMID: 25123959
The polycystins PC1 and PC2 are emerging as major players in mechanotransduction, a process that influences all steps of the invasion/metastasis cascade. We hypothesized that PC1 and PC2 facilitate cancer...
6.
Koufos N, Michailidou D, Xynos I, Tomos P, Athanasiadou K, Kosmas C, et al.
J Cancer Res Clin Oncol
. 2013 Sep;
139(12):1995-2003.
PMID: 24072231
Purpose: The aim of this study was to assess systemic immunological responses in non-small-cell lung cancer (NSCLC) patients with stage III/IV disease during treatment with paclitaxel-ifosfamide-cisplatin (TIP) chemotherapy. Methods: Peripheral...
7.
Koumarianou A, Chatzellis E, Boutzios G, Tsavaris N, Kaltsas G
Endokrynol Pol
. 2013 Mar;
64(1):60-72.
PMID: 23450449
Poorly differentiated neuroendocrine carcinomas (PDNEC) are rare tumours that can originate from any site of the gastrointestinal tract exhibiting an overall aggressive behaviour that may vary between tumours according to...
8.
Koumarianou A, Antoniou S, Kanakis G, Economopoulos N, Rontogianni D, Ntavatzikos A, et al.
Endocr Relat Cancer
. 2012 Jan;
19(1):L1-4.
PMID: 22232542
No abstract available.
9.
Tsavaris N, Voutsas I, Kosmas C, Gritzapis A, Baxevanis C
Invest New Drugs
. 2010 Sep;
30(1):395-402.
PMID: 20820907
Background: Bevacizumab, a monoclonal antibody (mAb) targeting vascular endothelial growth factor (VEGF), has produced promising results when combined with chemotherapy in the treatment of advanced colorectal cancer (CRC). The aim...
10.
Lekka E, Gritzapis A, Perez S, Tsavaris N, Missitzis I, Mamalaki A, et al.
Cancer Immunol Immunother
. 2009 Nov;
59(5):715-27.
PMID: 19904532
Our aim is to develop peptide vaccines that stimulate tumor antigen-specific T-lymphocyte responses against frequently detected cancers. We describe herein a novel HLA-A*0201-restricted epitope, encompassing amino acids 828-836 (residues QIAKGMSYL),...